DE602004011790D1 - Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung - Google Patents
Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzungInfo
- Publication number
- DE602004011790D1 DE602004011790D1 DE602004011790T DE602004011790T DE602004011790D1 DE 602004011790 D1 DE602004011790 D1 DE 602004011790D1 DE 602004011790 T DE602004011790 T DE 602004011790T DE 602004011790 T DE602004011790 T DE 602004011790T DE 602004011790 D1 DE602004011790 D1 DE 602004011790D1
- Authority
- DE
- Germany
- Prior art keywords
- salts
- sup
- acid
- meldonium
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- PVBQYTCFVWZSJK-UHFFFAOYSA-N meldonium Chemical class C[N+](C)(C)NCCC([O-])=O PVBQYTCFVWZSJK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical class OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 3
- 229960002937 meldonium Drugs 0.000 abstract 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 230000002045 lasting effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
- -1 Meldonium hydrogen salts Chemical class 0.000 abstract 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Chemical class OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 239000001530 fumaric acid Substances 0.000 abstract 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 239000011976 maleic acid Chemical class 0.000 abstract 1
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 abstract 1
- 235000006408 oxalic acid Nutrition 0.000 abstract 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical class C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 abstract 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
- C07C243/14—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/16—Halogenated acetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
- C07C55/07—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/14—Adipic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LV030087A LV13279B (en) | 2003-08-04 | 2003-08-04 | Non-hygroscopic salts of 3-(2,2,2-trimethylhydrazinum)propionate,a method of production and pharmaceutical compositions thereof |
LV030087 | 2003-08-04 | ||
LV030088A LV13280B (en) | 2003-08-04 | 2003-08-04 | Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof |
LV030088 | 2003-08-04 | ||
PCT/LV2004/000005 WO2005012233A1 (en) | 2003-08-04 | 2004-07-15 | Meldonium salts, method of their preparation and pharmaceutical composition on their basis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602004011790D1 true DE602004011790D1 (de) | 2008-03-27 |
DE602004011790T2 DE602004011790T2 (de) | 2009-03-05 |
Family
ID=34118016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004011790T Expired - Lifetime DE602004011790T2 (de) | 2003-08-04 | 2004-07-15 | Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung |
Country Status (23)
Country | Link |
---|---|
US (1) | US7223797B2 (de) |
EP (1) | EP1667960B1 (de) |
JP (1) | JP4634380B2 (de) |
KR (1) | KR100745160B1 (de) |
AT (1) | ATE386014T1 (de) |
AU (1) | AU2004260779B2 (de) |
CA (1) | CA2535150C (de) |
DE (1) | DE602004011790T2 (de) |
DK (1) | DK1667960T3 (de) |
EA (1) | EA009083B1 (de) |
ES (1) | ES2302011T3 (de) |
HK (1) | HK1093197A1 (de) |
HR (1) | HRP20080192T3 (de) |
IL (1) | IL173126A (de) |
MA (1) | MA28025A1 (de) |
MX (1) | MXPA06000955A (de) |
NO (1) | NO334623B1 (de) |
NZ (1) | NZ545440A (de) |
PL (1) | PL1667960T3 (de) |
PT (1) | PT1667960E (de) |
SI (1) | SI1667960T1 (de) |
UA (1) | UA82540C2 (de) |
WO (1) | WO2005012233A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LV13450B (en) * | 2004-08-24 | 2006-11-20 | Grindeks As | Novel medicinal use of meldonium and pharmaceutical compositions thereof |
US10183001B1 (en) * | 2007-05-22 | 2019-01-22 | Pisgah Laboratories, Inc. | Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features |
TW200930356A (en) * | 2007-12-04 | 2009-07-16 | Grindeks Jsc | New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts |
TWI391131B (zh) * | 2007-12-05 | 2013-04-01 | Grindeks Jsc | 3-(2,2,2-三甲基肼)丙酸鹽的新用途 |
ES2364017T3 (es) | 2007-12-05 | 2011-08-23 | Grindeks, A Joint Stock Company | Sales de propionato de 3-(2,2,2-trimethylhydrazinium) para el tratamiento del infarto de miocardio. |
EP2067474A1 (de) | 2007-12-05 | 2009-06-10 | Grindeks, a joint stock company | Neue medizinische Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionat-Salz |
WO2009074498A1 (en) * | 2007-12-12 | 2009-06-18 | Grindeks | Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate |
WO2009095445A1 (en) * | 2008-01-29 | 2009-08-06 | Grindeks | New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate |
GEP20125680B (en) * | 2008-02-19 | 2012-10-25 | Grindex Publiska As | Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydra-zinium) ropionate esters and their use for 3-(2,2,2-rimethyl- hydrazinium) propionate dihydrate preparation |
EA016876B1 (ru) * | 2008-05-26 | 2012-08-30 | Гриндекс, Джоинт Сток Кампани | Способ получения дигидрата 3-(2,2,2-триметилгидразиниум) пропионата |
EP2128126A1 (de) * | 2008-05-26 | 2009-12-02 | Grindeks, a joint stock company | Neues Verfahren zur Herstellung von 3-(2,2,2-Trimethylhydrazinium) Propionat-Dihydrat |
GEP20135819B (en) * | 2008-10-29 | 2013-05-10 | Grindeks Jsc | 3-(2,2,2-trimethylhydrazinium) propionate dihydrate composition of local administration |
LV14230B (lv) * | 2009-04-30 | 2011-05-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai |
WO2010149654A1 (en) * | 2009-06-25 | 2010-12-29 | Grindeks, A Joint Stock Company | Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt |
BRPI1009600A2 (de) * | 2009-06-25 | 2016-03-22 | Tetra S A | |
LV14268B (lv) * | 2009-06-25 | 2011-03-20 | Grindeks, A/S | Meldonija sukcinātu saturoši medicīniskie produkti |
LV14274B (lv) * | 2009-06-25 | 2011-03-20 | Grindeks, A/S | Meldoniju saturošs kombinēts medicīniskais produkts |
EP2399904A1 (de) * | 2010-05-26 | 2011-12-28 | Nabriva Therapeutics AG | Verfahren zur Herstellung von Pleuromutilinen |
EP2420224A1 (de) * | 2010-08-11 | 2012-02-22 | Grindeks, a joint stock company | Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung aus stabilem 3-(2,2,2-trimethylhydrazinium)propionatdihydrat |
PE20140777A1 (es) * | 2011-04-27 | 2014-07-20 | Grindeks Jsc | Metodo de obtencion de una composicion farmaceutica de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio para el tratamiento de enfermedades cardiovasculares |
RU2458690C1 (ru) * | 2011-05-31 | 2012-08-20 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее противоишемической активностью |
RU2457198C1 (ru) * | 2011-05-31 | 2012-07-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью |
RU2467745C1 (ru) * | 2011-08-08 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью |
RU2467744C1 (ru) * | 2011-08-08 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-гидрокисиникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью |
RU2485953C1 (ru) * | 2012-04-12 | 2013-06-27 | Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" | Комплекс 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцинат, обладающий антигипоксическим и адаптогенным действием, и способ его получения |
LV14848B (lv) * | 2012-10-25 | 2015-06-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai |
RU2527347C1 (ru) * | 2013-03-12 | 2014-08-27 | Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" | Стабильная жидкая фармацевтическая композиция комплекса 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцината, обладающая антигипоксическим, антиоксидантным и адаптогенным действием |
EP2842557A1 (de) * | 2013-08-30 | 2015-03-04 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Mildronat bei Augenerkrankungen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU997646A1 (ru) | 1978-11-27 | 1983-02-23 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Кормова добавка |
SU978808A1 (ru) * | 1980-01-18 | 1982-12-07 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Способ регулировани роста растений люпина |
SU1680693A1 (ru) * | 1987-03-25 | 1991-09-30 | Институт Органического Синтеза Ан Латвсср | Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность |
EP0307977B1 (de) * | 1987-09-07 | 1992-09-30 | Teikoku Tsushin Kogyo Co. Ltd. | Gehäuse aus vergossenem Kunststoff für einen elektronischen Teil mit flachem Kabel |
LV11727B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
-
2004
- 2004-07-15 AT AT04748553T patent/ATE386014T1/de active
- 2004-07-15 CA CA2535150A patent/CA2535150C/en not_active Expired - Fee Related
- 2004-07-15 WO PCT/LV2004/000005 patent/WO2005012233A1/en active IP Right Grant
- 2004-07-15 JP JP2006522512A patent/JP4634380B2/ja not_active Expired - Fee Related
- 2004-07-15 DE DE602004011790T patent/DE602004011790T2/de not_active Expired - Lifetime
- 2004-07-15 DK DK04748553T patent/DK1667960T3/da active
- 2004-07-15 SI SI200430711T patent/SI1667960T1/sl unknown
- 2004-07-15 EA EA200600175A patent/EA009083B1/ru unknown
- 2004-07-15 US US10/567,130 patent/US7223797B2/en not_active Expired - Lifetime
- 2004-07-15 AU AU2004260779A patent/AU2004260779B2/en not_active Ceased
- 2004-07-15 ES ES04748553T patent/ES2302011T3/es not_active Expired - Lifetime
- 2004-07-15 PL PL04748553T patent/PL1667960T3/pl unknown
- 2004-07-15 EP EP04748553A patent/EP1667960B1/de not_active Expired - Lifetime
- 2004-07-15 PT PT04748553T patent/PT1667960E/pt unknown
- 2004-07-15 MX MXPA06000955A patent/MXPA06000955A/es active IP Right Grant
- 2004-07-15 KR KR1020067002265A patent/KR100745160B1/ko not_active IP Right Cessation
- 2004-07-15 NZ NZ545440A patent/NZ545440A/xx not_active IP Right Cessation
- 2004-07-15 UA UAA200601710A patent/UA82540C2/uk unknown
-
2005
- 2005-12-09 NO NO20055867A patent/NO334623B1/no not_active IP Right Cessation
-
2006
- 2006-01-12 IL IL173126A patent/IL173126A/en not_active IP Right Cessation
- 2006-03-03 MA MA28856A patent/MA28025A1/fr unknown
- 2006-12-19 HK HK06113946.2A patent/HK1093197A1/xx not_active IP Right Cessation
-
2008
- 2008-04-28 HR HR20080192T patent/HRP20080192T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005012233A1 (en) | 2005-02-10 |
NO334623B1 (no) | 2014-04-28 |
EA009083B1 (ru) | 2007-10-26 |
KR100745160B1 (ko) | 2007-08-01 |
CA2535150A1 (en) | 2005-02-10 |
UA82540C2 (uk) | 2008-04-25 |
JP4634380B2 (ja) | 2011-02-16 |
EP1667960B1 (de) | 2008-02-13 |
NO20055867L (no) | 2006-02-27 |
EP1667960A1 (de) | 2006-06-14 |
PT1667960E (pt) | 2008-05-02 |
MXPA06000955A (es) | 2006-03-30 |
MA28025A1 (fr) | 2006-07-03 |
AU2004260779B2 (en) | 2009-01-22 |
IL173126A (en) | 2011-02-28 |
ATE386014T1 (de) | 2008-03-15 |
US7223797B2 (en) | 2007-05-29 |
DE602004011790T2 (de) | 2009-03-05 |
ES2302011T3 (es) | 2008-07-01 |
SI1667960T1 (sl) | 2008-08-31 |
US20060264506A1 (en) | 2006-11-23 |
AU2004260779A1 (en) | 2005-02-10 |
PL1667960T3 (pl) | 2008-06-30 |
KR20060059995A (ko) | 2006-06-02 |
DK1667960T3 (da) | 2008-06-09 |
NZ545440A (en) | 2009-03-31 |
JP2007501222A (ja) | 2007-01-25 |
EA200600175A1 (ru) | 2006-08-25 |
WO2005012233A8 (en) | 2005-05-19 |
HRP20080192T3 (en) | 2008-05-31 |
CA2535150C (en) | 2010-04-13 |
HK1093197A1 (en) | 2007-02-23 |
IL173126A0 (en) | 2006-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004011790D1 (de) | Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung | |
RU2196769C2 (ru) | Производные аминобензойной кислоты, фармацевтическая композиция | |
ATE31411T1 (de) | Piperazin-derivate, verfahren zu ihrer herstellung und diese als aktive bestandteile enthaltende pharmazeutische zusammensetzungen. | |
HUP0102602A2 (hu) | Diacil-hidrazinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
DE59509647D1 (de) | Aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
RU2005109560A (ru) | Фармацевтическая композиция, включающая кристаллический полугидрат метансульфоната сибутрамина | |
HUP9903632A2 (hu) | Neuraminsav vegyületek, azokat tartalmazó gyógyszerkészítmények és eljárás e készítmények előállítására | |
JPH08510477A (ja) | 新規なn−ベンゾイルメチル−ピペリジン類 | |
HK1075656A1 (en) | New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds | |
ATE365162T1 (de) | Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten | |
RU2342363C2 (ru) | Бензоилпиперидиновые соединения | |
JP5107497B2 (ja) | 鎮咳活性を有する1,3−ジオキソラン | |
JPH09502200A (ja) | インドリジン誘導体の製造法 | |
DE60227506D1 (de) | DIHYDROIMIDAZOi5,1-A -BETA-CARBOLIN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE ANWENDUNG ALS ARZNEIMITTEL | |
HU196159B (en) | Process for producing aphidicolin derivatives and pharmaceutics comprising the same as active ingredient | |
KR20210125298A (ko) | 테노포비어 알라펜아미드 헤미타르트레이트의 신규한 제조방법 | |
JPH05271220A (ja) | アミン誘導体およびこれを含有する降圧剤 | |
GB0114699D0 (en) | Organic compounds | |
JP2001039957A (ja) | 新規ベンゾオキサゾール誘導体 | |
JPS59190982A (ja) | 4’−フルオロメチル−3−アミノ−2−メチル置換プロピオフエノン誘導体 | |
NO20022891L (no) | Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem | |
HU229801B1 (en) | 2,2-disubstituted 1,3-dioxolanes as antitussive agents | |
TH88189B (th) | สารก่อนเป็นยา (prodrug) ที่มีฐานเป็นฟอสฟอนิก แอซิดชนิดใหม่ของ ของ 9-(2-ฟอสฟอนิลเอธอกซิเอธิล)แอเดนีน(PMEA)และแอนะล็อก(analogues) ของมัน | |
JPS59190980A (ja) | 2’−クロロ−3−アミノ−2−メチル置換プロピオフエノン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |